How Kappa Opioid Receptors Drive Anxiety

How Kappa Opioid Receptors Drive Anxiety

Mood disorders and chronic pain are related on multiple levels. The genes that regulate the synthesis of serotonin transporter, opioid receptors, and inflammatory mediators seem to be compromised i…

Mood disorders and chronic pain are related on multiple levels. The genes that regulate the synthesis of serotonin transporter, opioid receptors, and inflammatory mediators seem to be compromised i…

Light -- not pain-killing drugs -- used to activate brain's opioid receptors -- ScienceDaily

Light -- not pain-killing drugs -- used to activate brain's opioid receptors

Light -- not pain-killing drugs -- used to activate brain's opioid receptors -- ScienceDaily

Kuvahaun tulos haulle mu opioid receptor gpcr camp

Kuvahaun tulos haulle mu opioid receptor gpcr camp

Light – not pain-killing drugs – used to activate brain’s opioid receptors

Light – not pain-killing drugs – used to activate brain’s opioid receptors

Despite the abuse potential of opioid drugs, they have long been the best option for patients suffering from severe pain. The drugs interact with receptors on brain cells to tamp down the body's pain response.

Kuvahaun tulos haulle mu opioid receptor gpcr camp

Kuvahaun tulos haulle mu opioid receptor gpcr camp

Kuvahaun tulos haulle mu opioid receptor gpcr camp

Kuvahaun tulos haulle mu opioid receptor gpcr camp

A cellular mechanism has been discovered by which kappa opioid receptors (KORs) drive anxiety. These proteins inhibit the release of the neurotransmitter glutamate in a part of the brain that regulates emotion. KORs are targets for the treatment of addiction and anxiety disorders.

How kappa opioid receptors drive anxiety

Are your BFFs as disposable as your razors? According to a new study, the mindset that objects are disposable extends to social ties.

Figures Show Less Number of Britons Drinking in Pubs

The Mu Opioid Receptor Genotype may be a Marker for Those Who Drink for Alcohol's Rewarding Effects: Study

Opioid receptor activation triggering downregulation of cAMP improves effectiveness of anti-cancer drugs in treatment of glioblastoma.  - PubMed - NCBI

Opioid receptor activation triggering downregulation of cAMP improves effectiveness of anti-cancer drugs in treatment of glioblastoma.

Pinterest
Search